120 likes | 132 Views
The MoVIES Project is a population-based dementia registry conducted in the mid-Monongahela Valley in Pennsylvania. It aims to study the epidemiology of dementia in the community. The project began in 1987 and followed participants for several years, identifying prevalent and incident cases of dementia. The project includes cognitive screening and clinical diagnostic evaluations. This dataset provides valuable insights into the prevalence, incidence, and risk factors of dementia in the region.
E N D
Epidemiology of Dementia: the MoVIES Project • Alzheimer’s Disease Patient Registry (ADPR ), University of Pittsburgh • Initially funded by NIA 1987-1989 under cooperative agreement, U01 AG06782: Population-based Dementia Registry: • Subsequently funded by NIA 1989-2002 as project grant R01, AG07562, Epidemiology of Dementia: A Prospective Community Study. • Locally called “Monongahela Valley Independent Elders Survey” (MoVIES). Home
MoVIES Project • Site: mid- Monongahela Valley in Washington and Westmoreland counties, Southwestern Pennsylvania; • 23 communities served by the 23 Mon Valley communities served by the Mon Valley Community Health Center, Monessen, PA. • Rural area with small towns, former home to coal mines and steel mills until the 1970s. Home
MoVIES Cohort • Random sample, N=1422 1:13 age-stratified (65-74, 75+ years) random sample drawn from Voter Registration lists for the selected communities. • Volunteer sample, N=259 drawn from same area, meeting same entry criteria. Home
MoVIES Entry Criteria • Age 65+ at time of recruitment; • Mon Valley resident; • Not in nursing home at time of recruitment; • Fluent in English; • At least Grade 6 education. Home
MoVIES Cohort Characteristics • Total sample size of original cohort: • N=1681 (random plus volunteer) • Age: Mean (SD) = 72.6 (5.7) yrs (baseline) • Sex ratio: F:M=55.5 : 45 • Education: % < high school graduate: 43.3% Home
MoVIES:Overview • Sample recruited 1987-1989 as part of ADPR; prevalent cases identified. • Began prospective followup in 1989; • Subjects re-assessed approximately every two years; incident cases identified. • Followup completed in 2002. Home
MMSE CERAD Word List (10) Learning (3 trials) Delayed Recall Delayed Recognition (originals and foils) Story Immediate Recall Delayed Recall Boston Naming (15) Word Fluency P&S Fruits & Animals CERAD Praxis (4) Clock Drawing Trailmaking A Trailmaking B Temporal Orientation MoVIES Screening Cognitive Tests Home
MoVIES:Study procedures • At each wave: • All consenting survivors: cognitive screening and risk factor assessment. • Screening identifies those who are • (a) cognitively “impaired;” • (b) cognitively “declined.” • Impaired and declined subjects undergo clinical diagnostic evaluation for dementia. Home
MoVIES Screening Criteria (1) Cognitive impairment: Actual scores, at any given time, at or below the 10th %ile of the sample on: • MMSE and/or • At least one memory test and one other test. Home
MoVIES Screening Criteria (2) Cognitive Decline: Decline over time in scores • To “impaired” levels, and/or • By amounts greater than or equal to that experienced by 95 % of the cohort on • MMSEand/or • At least two other tests. Home
MoVIES Clinical Evaluation (1) • In-home evaluation; • History and general physical exam; • Detailed neurological exam; • Brief mental status exam; • Psychiatric exam; • Blood: chemistry/hematology/serology; Home
MoVIES Clinical Evaluation (2) • Based on Pittsburgh ADRC/CERAD assessment protocols, modified for field use; • DSM-III-R criteria for dementia; • CDR rating for stage/severity; • NINCDS-ADRDA criteria for Probable and Possible AD. Home